Development of a time-resolved fluorescence immunoassay kit for detecting canine coronavirus and parvovirus through double labeling
- PMID: 38468354
- PMCID: PMC10929163
- DOI: 10.1186/s12985-024-02302-4
Development of a time-resolved fluorescence immunoassay kit for detecting canine coronavirus and parvovirus through double labeling
Abstract
Objective: Canine enteric coronavirus (CCV) and canine parvovirus type 2 (CPV-2) are the main pathogens responsible for acute gastroenteritis in dogs, and both single and mixed infections are common. This study aimed to establish a double-labeling time-resolved fluorescence immunoassay (TRFIA) to test and distinguish CCV and CPV-2 diseases.
Methods: A sandwich double-labeling TRFIA method was established and optimized using europium(III) (Eu3+)/samarium(III) (Sm3+) chelates. CCV/CPV-2 antigens were first captured by the immobilized antibodies. Then, combined with Eu3+/Sm3+-labeled paired antibodies, the Eu3+/Sm3+ fluorescence values were detected after dissociation to calculate the CCV/CPV-2 ratios. The performance, clinical performance and methodology used for laboratory (sensitivity, specificity, accuracy and stability) testing were evaluated.
Results: A double-label TRFIA for CCV and CPV-2 detection was optimized and established. The sensitivity of this TRFIA kit was 0.51 ng/mL for CCV and 0.80 ng/mL for CPV-2, with high specificity for CCV and CPV-2. All the accuracy data were less than 10%, and the recovery ranged from 101.21 to 110.28%. The kits can be temporarily stored for 20 days at 4 °C and can be stored for 12 months at temperatures less than - 20 °C. Based on a methodology comparison of 137 clinically suspected patients, there was no statistically significant difference between the TRFIA kit and the PCR method. Additionally, for CCV detection, the clinical sensitivity was 95.74%, and the clinical specificity was 93.33%. For CPV-2 detection, the clinical sensitivity was 92.86%, and the clinical specificity was 96.97%.
Conclusion: In this study, a double-label TRFIA kit was prepared for CCV and CPV-2 detection with high laboratory sensitivity, specificity, accuracy, stability, clinical sensitivity and specificity. This kit provides a new option for screening/distinguishing between CCV and CPV-2 and may help improve strategies to prevent and control animal infectious diseases in the future.
Keywords: Canine; Coronavirus; Double labeling; Kit; Parvovirus; Time-resolved fluorescence immunoassay.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Determination of parvovirus antigen in the vaccine using time-resolved fluorescence immunoassay.Biotechnol Appl Biochem. 2021 Jun;68(3):597-602. doi: 10.1002/bab.1967. Epub 2020 Jul 14. Biotechnol Appl Biochem. 2021. PMID: 32533780
-
Diagnostic Challenges in Canine Parvovirus 2c in Vaccine Failure Cases.Viruses. 2020 Sep 3;12(9):980. doi: 10.3390/v12090980. Viruses. 2020. PMID: 32899378 Free PMC article.
-
Sensitivity of lateral flow technique for diagnosis of canine parvovirus.Sci Rep. 2024 Mar 1;14(1):5060. doi: 10.1038/s41598-024-55548-x. Sci Rep. 2024. PMID: 38424259 Free PMC article.
-
Development and evaluation of a gold nanoparticle-based immunochromatographic strip test for the detection of canine parvovirus.Arch Virol. 2018 Sep;163(9):2359-2368. doi: 10.1007/s00705-018-3846-2. Epub 2018 May 8. Arch Virol. 2018. PMID: 29736673
-
Canine parvovirus--a review of epidemiological and diagnostic aspects, with emphasis on type 2c.Vet Microbiol. 2012 Feb 24;155(1):1-12. doi: 10.1016/j.vetmic.2011.09.007. Epub 2011 Sep 12. Vet Microbiol. 2012. PMID: 21962408 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources